Literature DB >> 12597246

Superoxide dismutase activity and glutathione system in erythrocytes of men with Behchet's disease.

Yildiz Dincer1, Zeynep Alademir, Vedat Hamuryudan, Izzet Fresko, Tulay Akcay.   

Abstract

In order to clarify whether erythrocyte superoxide dismutase (SOD) activity and glutathione system including reduced glutathione (GSH), glutathione peroxidase (G-Px), glutathione reductase (G-Red), glutathione S-transferase (GST) are impaired in men with Behchet's disease (BD) at the first diagnosed time, erythrocyte SOD activity, GSH level, activities of G-Px, G-Red and GST were determined in men with new diagnosed BD. Erythrocyte GSH level, G-Px and G-Red activities were found to be lower, SOD activity was found to be higher in the patients as compared the controls. There was no significant difference between patients and controls for GST activity. Significant positive correlations between GSH and G-Px, GSH and G-Red; significant negative correlations between GSH and SOD, G-Px and SOD, G-Red and SOD were determined. It was concluded that erythrocyte SOD activity and glutathione system are altered in men with new diagnosed BD. It was concluded that these alterations may be a contributory factor for tissue damage associated with BD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12597246     DOI: 10.1620/tjem.198.191

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  3 in total

1.  Oxidant/antioxidant status in men with Behçet's disease.

Authors:  Seyithan Taysi; Berna Demircan; Necmettin Akdeniz; Mustafa Atasoy; Refik Ali Sari
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 2.980

2.  Increased oxidative stress in patients with familial Mediterranean fever during attack period.

Authors:  L Ediz; H Ozkol; I Tekeoglu; Y Tuluce; E Gulcu; I Koyuncu
Journal:  Afr Health Sci       Date:  2011-08       Impact factor: 0.927

3.  Genetic Polymorphism of Manganese Superoxide Dismutase in Behçet's Disease.

Authors:  Efkan Uz; H Ramazan Yilmaz; Ramazan Yağci; İsmail Akyol; Tuğba Ersoy; Gülten Sungur; Ayşe Yiğit; Sunay Duman; Ömer Akyol
Journal:  Arch Rheumatol       Date:  2015-12-14       Impact factor: 1.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.